[Evaluation of circulating microRNA-92a for endothelial damage induced by percutaneous coronary intervention]

Hong Wang1, Lin Wang, Ling Liu

  • 1Department of Cardiovascular Disease, Guangxi People's Hospital, Nanning 530021, Guangxi, China.

Abstract

Insights

Circulating microRNA-92a (miR-92a) levels correlate with percutaneous coronary intervention (PCI) parameters. Lower miR-92a indicates potential endothelium damage, suggesting its use in evaluating PCI-induced injury.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Biomarker Discovery

Context:

  • Percutaneous coronary intervention (PCI) is a common procedure for treating coronary artery disease.
  • Endothelial dysfunction is a significant complication following PCI.
  • Identifying reliable biomarkers for assessing PCI-induced endothelial injury is crucial.

Purpose:

  • To investigate the association between circulating microRNA-92a (miR-92a) levels and endothelial damage after PCI.
  • To explore the correlation of miR-92a expression with procedural factors of PCI, including inflation pressure, balloon inflation duration, and stent length.

Summary:

  • A case-control study involving 58 patients with ST-segment elevation acute myocardial infarction (STEMI) undergoing PCI was conducted.
  • Circulating miR-92a levels were measured post-PCI and correlated with procedural parameters.
  • Results indicated lower miR-92a levels with increased inflation pressure, longer balloon inflation duration, and longer stent length, alongside a negative correlation between inflation pressure and balloon duration.

Impact:

  • Circulating miR-92a shows potential as a biomarker for evaluating PCI-induced endothelial injury.
  • miR-92a may serve as a novel therapeutic target for preventing and treating post-PCI endothelial dysfunction.
  • This research contributes to optimizing PCI procedures and improving patient outcomes.

Related Concept Videos